Novo Nordisk is working on a new obesity drug that could help patients shed ... could reignite Novo shares. Semaglutide, the ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues.

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.